[go: up one dir, main page]

AR023562A1 - Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento - Google Patents

Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Info

Publication number
AR023562A1
AR023562A1 ARP000101863A ARP000101863A AR023562A1 AR 023562 A1 AR023562 A1 AR 023562A1 AR P000101863 A ARP000101863 A AR P000101863A AR P000101863 A ARP000101863 A AR P000101863A AR 023562 A1 AR023562 A1 AR 023562A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
tiazolidin
diona
understands
derived
Prior art date
Application number
ARP000101863A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR023562A1 publication Critical patent/AR023562A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Dihidrato de hidrocloruro de 5-[4-[2-N-metil-N-(2-piridil)amino)-etoxi]bencil]tiazolidina-2,4-diona caracterizado porque (i) proporciona un espectroinfrarrojo que contiene picos a 3.392, 2.739, 1.751, 1.325 y 713cm-1 y/o (ii) proporciona un modelo dedifraccion de rayos X a través de polvo (XRPD) quecontiene picos a 9,1, 12,0,15,7,16,3 y 19,8*2theta, un procedimiento para preparar dicho compuesto, una composicion farmacéutica que contiene dicho compuesto yel uso de dicho compuesto en medicina.
ARP000101863A 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento AR023562A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR023562A1 true AR023562A1 (es) 2002-09-04

Family

ID=10851901

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona
ARP000101863A AR023562A1 (es) 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona

Country Status (42)

Country Link
EP (2) EP1173436B1 (es)
JP (2) JP4283449B2 (es)
KR (1) KR100601244B1 (es)
CN (2) CN101134756A (es)
AP (1) AP1562A (es)
AR (2) AR023566A1 (es)
AT (1) ATE268770T1 (es)
AU (2) AU4130900A (es)
BG (1) BG65864B1 (es)
BR (1) BR0009897A (es)
CA (1) CA2382036A1 (es)
CO (1) CO5170422A1 (es)
CZ (1) CZ300653B6 (es)
DE (1) DE60011419T2 (es)
DK (1) DK1173436T3 (es)
DZ (1) DZ3162A1 (es)
EA (1) EA004232B1 (es)
EG (1) EG24063A (es)
ES (1) ES2218146T3 (es)
GB (1) GB9909041D0 (es)
HK (1) HK1045151B (es)
HR (1) HRP20010770B1 (es)
HU (1) HUP0200865A3 (es)
IL (1) IL146078A0 (es)
MA (1) MA26783A1 (es)
MX (1) MXPA01010696A (es)
MY (1) MY126034A (es)
NO (1) NO320609B1 (es)
NZ (1) NZ515166A (es)
OA (1) OA11866A (es)
PE (1) PE20010050A1 (es)
PL (1) PL351135A1 (es)
PT (1) PT1173436E (es)
RS (1) RS50136B (es)
SI (1) SI1173436T1 (es)
SK (1) SK284991B6 (es)
TR (1) TR200103040T2 (es)
TW (1) TWI277616B (es)
UA (1) UA71615C2 (es)
UY (1) UY26112A1 (es)
WO (1) WO2000063205A2 (es)
ZA (1) ZA200108720B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
PT1448559E (pt) * 2001-11-21 2007-03-30 Smithkline Beecham Plc Benzenossulfonato de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)benzil)tiazolidina-2, 4-diona; processo para a sua preparação; seus polimorfos i, ii e iii; e sua utilização como ingrediente farmacêutico activo
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP1173436A2 (en) 2002-01-23
SK284991B6 (sk) 2006-04-06
GB9909041D0 (en) 1999-06-16
EA004232B1 (ru) 2004-02-26
EA200101101A1 (ru) 2002-04-25
BG65864B1 (bg) 2010-03-31
HRP20010770A2 (en) 2002-10-31
AP2001002331A0 (en) 2000-04-19
UY26112A1 (es) 2000-12-29
JP2009143954A (ja) 2009-07-02
ES2218146T3 (es) 2004-11-16
UA71615C2 (uk) 2004-12-15
SI1173436T1 (en) 2004-12-31
AU4130900A (en) 2000-11-02
RS50136B (sr) 2009-03-25
DE60011419T2 (de) 2005-06-16
MY126034A (en) 2006-09-29
OA11866A (en) 2006-03-02
TR200103040T2 (tr) 2002-04-22
DK1173436T3 (da) 2004-09-27
KR100601244B1 (ko) 2006-07-19
HUP0200865A3 (en) 2005-04-28
DE60011419D1 (de) 2004-07-15
PE20010050A1 (es) 2001-03-10
HK1045151A1 (en) 2002-11-15
CN101134756A (zh) 2008-03-05
ZA200108720B (en) 2002-11-28
MXPA01010696A (es) 2002-06-04
PT1173436E (pt) 2004-10-29
CN1327447A (zh) 2001-12-19
BG106112A (bg) 2002-05-31
AU2755202A (en) 2002-05-16
DZ3162A1 (fr) 2000-10-26
SK14902001A3 (sk) 2002-02-05
TWI277616B (en) 2007-04-01
AU765911B2 (en) 2003-10-02
WO2000063205A2 (en) 2000-10-26
HK1045151B (zh) 2005-03-18
AP1562A (en) 2006-02-01
WO2000063205A3 (en) 2001-01-25
CO5170422A1 (es) 2002-06-27
HUP0200865A2 (en) 2002-08-28
ATE268770T1 (de) 2004-06-15
PL351135A1 (en) 2003-03-24
CA2382036A1 (en) 2000-10-26
IL146078A0 (en) 2002-07-25
NO20015104D0 (no) 2001-10-19
JP4283449B2 (ja) 2009-06-24
KR20010110791A (ko) 2001-12-13
AR023566A1 (es) 2002-09-04
EP1411055A1 (en) 2004-04-21
NO20015104L (no) 2001-12-19
MA26783A1 (fr) 2004-12-20
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
YU81501A (sh) 2004-07-15
HRP20010770B1 (en) 2005-06-30
JP2002542242A (ja) 2002-12-10
EP1173436B1 (en) 2004-06-09
BR0009897A (pt) 2002-04-16
NZ515166A (en) 2004-02-27
NO320609B1 (no) 2005-12-27
CZ20013759A3 (cs) 2002-05-15

Similar Documents

Publication Publication Date Title
AR011759A1 (es) Compuesto derivado de fenoximetilpiperidina, procedimientos para su preparacion, una composicion farmaceutica, el uso del mismo para la preparacion de un medicamento, para la preparacion de un producto intermedio, un solvato y un envase
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
ATE144503T1 (de) Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ME00318B (me) Nova kompozicija i njena upotreba
AR023564A1 (es) Una forma polimorfica de sal del acido maleico derivado del tiazolidina-2,4 diona, una composicion farmaceutica y el uso del mismo para la fabricacion deun medicamento
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
AR023562A1 (es) Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento
DE69815094D1 (de) 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen
DE59909606D1 (de) Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
ES2076894A1 (es) Derivados de 2-(4-(4-azolibutil)-1-piperacinil)-5-hidroxipirimidina, su preparacion y su aplicacion como medicamentos.
ECSP034469A (es) Compuesto farmaceutico novedoso
DE69910600D1 (de) Verwendung von metformin gegen die gewichtszunahme, die mit valproat und andere psychotropische arzneimittel verbunden ist
ECSP003434A (es) Nuevos compuestos
GB0021978D0 (en) Novel pharmaceutical
NZ243552A (en) 2-[2-(4-methoxy-2-pyridinyl)phenylsulphinyl]-1h-benzimidazole derivatives, preparation and pharmaceutical compositions thereof
ECSP034467A (es) Farmaceutico novedoso
CY1107421T1 (el) Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
ATE334675T1 (de) Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FG Grant, registration